These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19891349)

  • 61. [Clinical and immunochemical characteristics of remittent multiple sclerosis].
    Gusev EI; Beliaeva IA; Chekhonin VP; Demina TL; Boĭko AN; Buglak AV; Gurina OI
    Vestn Ross Akad Med Nauk; 1999; (7):40-5. PubMed ID: 10467884
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis.
    Adamczyk B; Adamczyk-Sowa M
    Oxid Med Cell Longev; 2016; 2016():1973834. PubMed ID: 27829982
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The metabolic characteristics of patients with multiple sclerosis].
    Shtybel' VH
    Lik Sprava; 1998; (5):89-91. PubMed ID: 9793316
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis.
    Koch M; Mostert J; Arutjunyan A; Stepanov M; Teelken A; Heersema D; De Keyser J
    Mult Scler; 2008 Mar; 14(2):159-65. PubMed ID: 17942516
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Glutathione in multiple sclerosis.
    Ferreira B; Mendes F; Osório N; Caseiro A; Gabriel A; Valado A
    Br J Biomed Sci; 2013; 70(2):75-9. PubMed ID: 23888609
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of the Diagnostic and Predictive Value of Serum Levels of ANT1, ATG5, and Parkin in Multiple Sclerosis.
    Joodi Khanghah O; Nourazarian A; Khaki-Khatibi F; Nikanfar M; Laghousi D; Vatankhah AM; Moharami S
    Clin Neurol Neurosurg; 2020 Oct; 197():106197. PubMed ID: 32890892
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis.
    Khalatbari Mohseni G; Hosseini SA; Majdinasab N; Cheraghian B
    Neuropsychopharmacol Rep; 2023 Sep; 43(3):382-390. PubMed ID: 37386885
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Redox processes in neurodegenerative disease involving reactive oxygen species.
    Kovacic P; Somanathan R
    Curr Neuropharmacol; 2012 Dec; 10(4):289-302. PubMed ID: 23730253
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial.
    Khalili M; Eghtesadi S; Mirshafiey A; Eskandari G; Sanoobar M; Sahraian MA; Motevalian A; Norouzi A; Moftakhar S; Azimi A
    Nutr Neurosci; 2014 Jan; 17(1):16-20. PubMed ID: 23485514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.
    Polachini CR; Spanevello RM; Zanini D; Baldissarelli J; Pereira LB; Schetinger MR; da Cruz IB; Assmann CE; Bagatini MD; Morsch VM
    Neurotox Res; 2016 Feb; 29(2):230-42. PubMed ID: 26690779
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
    Adamczyk-Sowa M; Sowa P; Pierzchala K; Polaniak R; Labuz-Roszak B
    J Physiol Pharmacol; 2012 Dec; 63(6):683-90. PubMed ID: 23388485
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
    Acar A; Ugur Cevik M; Evliyaoglu O; Uzar E; Tamam Y; Arıkanoglu A; Yucel Y; Varol S; Onder H; Taşdemir N
    Acta Neurol Belg; 2012 Sep; 112(3):275-80. PubMed ID: 22450709
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Parameters of antioxidant protection in multiple sclerosis].
    Krotenko NV; Alifirova VM; Ivanova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):53-6. PubMed ID: 19891349
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Oxidative stress in multiple sclerosis].
    Miller E; Mrowicka M; Zołyński K; Kedziora J
    Pol Merkur Lekarski; 2009 Dec; 27(162):499-502. PubMed ID: 20120717
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.